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ABSTRACT: 26 
Background and aim: Several measures have been developed to assess the 27 
health related quality of life (HRQoL) of patients with inflammatory bowel 28 
disease (IBD). Our aim is to systematically review the HRQoL measures 29 
specific for patients with IBD and to appraise their measurement properties 30 
and methodological quality.  31 
Methods: We searched the PubMed, Embase and PsycINFO databases for 32 
original articles describing the development and/or evaluation of one or more 33 
of the measurement properties (e.g., internal consistency, reliability, validity, 34 
responsiveness) of HRQoL measures specific for IBD. We assessed the 35 
measurement properties and examined the methodological quality of the 36 
measurement properties of each instrument using a standardized checklist.  37 
Results:  We examined the full text of 75 articles that we deemed potentially 38 
eligible and identified 10 disease specific HRQoL measures in IBD that 39 
covered different aspects of patients’ lives.  Internal consistency, construct 40 
validity and content validity were the commonly evaluated measurement 41 
properties. Seven HRQoL measures scored positive for at least four of eight 42 
measurement properties. The majority of studies were rated as “fair” to “poor” 43 
when assessing their methodology quality. The most established HRQoL in 44 
the literature was the Inflammatory Bowel Disease Questionnaire (IBDQ).  45 
Conclusions:  Most of the included HRQoL measures did not include all the 46 
required measurement properties or had a problem with their methodological 47 
quality. The most widely used and validated measure was the IBDQ.  Further 48 
validation studies are required to support the use of other HRQoL measures.   49 
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INTRODUCTION 50 
Inflammatory bowel disease (IBD) is known to impair quality of life (1-4) and 51 
cause a substantial burden to patients, their families and the society (4-7).  It 52 
affects patients’ lives mentally, emotionally, socially and physically (7, 8).  53 
Health related Quality of life (HRQoL) is a multidimensional concept that 54 
measures physical, emotional, mental and social impact of the disease on 55 
patients lives (9). Measuring HRQoL provides an important insight into 56 
patients’ perception of their health and the effect of treatments. Instruments 57 
used to measure HRQOL may be generic or disease-specific. Disease-58 
specific instruments assess domains specific to a given disease and are 59 
therefore considered more sensitive to changes in the patient's health state 60 
(10). Generic instruments, by contrast, are aimed at measuring the overall 61 
HRQoL of patients and therefore, are useful to compare HRQoL across 62 
different disease states as well as for the evaluation of health economics 63 
outcomes (11, 12).  64 
In the last two decades measurement of health related quality of life (HRQoL) 65 
has been increasingly used in inflammatory bowel disease (IBD) to support 66 
both research and clinical care (1, 13-19). This has led to a better evaluation 67 
of the patients’ health and subsequently to improvements in their quality of 68 
care (15, 16). In scientific research, these measures are important to evaluate 69 
the effectiveness of new therapies in clinical trials. An up-to-date systematic 70 
review will provide a useful resource for research professionals and IBD 71 
specialists to ensure they can select an appropriate HRQoL measure for 72 
patients in their practice. 73 
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The aim of this article is to systematically review the current health related 74 
quality of life (HRQoL) measures specific for patients with IBD and to appraise 75 
their measurement properties using a robust evaluation methodology 76 
checklist.  77 
 78 
 79 
 80 
 81 
 82 
 83 
 84 
 85 
 86 
 87 
 88 
 89 
 90 
 91 
 92 
 93 
 94 
 95 
 96 
 97 
 98 
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METHODS 99 
Search strategy 100 
This systematic review was undertaken in line with search strategies checklist 101 
of the Cochrane review group (20) and followed the PRISMA (Preferred 102 
Reporting Items for Systematic Reviews and Meta Analysis) statement (21) 103 
(Appendix 1).  104 
We searched the following electronic databases via Ovid SP up to 1st of 105 
October 2013: MEDLINE, EMBASE, and PsychoINFO. Key search terms and 106 
add synonyms were searched separately in three main filters that were 107 
merged together. Targeted hand searches using the names of measures 108 
identified in the initial searches were carried out. The detailed search strategy 109 
can be found in Appendix 2. 110 
1. Target population: Inflammatory bowel disease, Crohn’s disease, 111 
ulcerative colitis, terminal ileitis, regional ileitis, granulomatous enteritis, 112 
proctitis, proctocolitis, and colitis. 113 
2. Construct: quality of life, health related outcome measure, patient-114 
reported outcome measure, disability, health status, health related 115 
quality of life, health status measures, patient outcome assessment, 116 
and questionnaire. 117 
3. Psychometric properties of HRQoL measures: psychometrics, 118 
reproducibility, reliability, validation studies, validation, face validity, 119 
content validity, construct validity, concurrent validity, convergent 120 
validity, and discriminant validity.  121 
 122 
Selection criteria 123 
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We included all original articles in English describing the development and/or 124 
evaluation of one or more of the measurement properties (e.g., internal 125 
consistency, reliability, validity, responsiveness) of the HRQoL measures 126 
specific for patients with IBD. Articles were included if they sought to assess 127 
at least one domain of quality of life in IBD.  128 
Two reviewers (LA and IR) independently screened titles, abstracts and the 129 
references of these articles to obtain any additional articles of relevance. Full 130 
texts of eligible articles were obtained. If any disagreement existed regarding 131 
the inclusion or exclusion of articles, a third independent reviewer was 132 
consulted.  133 
 134 
Data Extraction 135 
Data from eligible articles were extracted independently using a pre-prepared 136 
data extraction proforma. The following data were extracted: 137 
1. Different disease specific HRQoL measures. For each questionnaire 138 
we identified the dimensions of HRQoL that were assessed (e.g. social, 139 
work, disease burden Ketc.). 140 
2. Measurement properties: we assessed the measurement properties of 141 
each HRQoL measure using the quality properties checklist proposed 142 
by Terwee et al (22)  (Table 1) which were: (1) reliability (including 143 
internal consistency, reliability, and measurement error), (2) validity 144 
(including content validity, structural validity and hypothesis testing 145 
(construct validity)), and (3) responsiveness.  146 
3. Methodology quality assessment: we reported on the methodological 147 
quality of the original development studies for the included HRQoL 148 
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measures using the COSMIN (COnsensus-based Standards for the 149 
selection of health Measurement Instruments) checklist (23, 24). The 150 
COSMIN checklist assesses the methodology quality of the internal 151 
consistency, reliability, measurement error, responsiveness, content 152 
validity, construct validity, and factor analysis (structural validity). Each 153 
measurement property methodology was assessed against certain 154 
quality standards and rated on a 4-point scale (1=poor, 2=fair, 3=good 155 
or 4=excellent). The overall score for the methodological quality of a 156 
certain property is determined by taking the lowest rating. Depending 157 
on the number of measurement properties assessed in a study, some 158 
studies received one quality evaluation whereas other studies received 159 
several. The measurement property of a study was rated as having 160 
‘excellent’ quality if all relevant COSMIN items were scored adequate.  161 
4. Levels of the HRQoL measure establishment or use in literature: we 162 
used Cohen’s criteria (25) (table 2) to determine the level of 163 
establishment of each specific HRQoL measure. The Cohen criteria 164 
classify the measures into three levels of establishment depending on 165 
the number of publications, the extent to which the measures are 166 
described in literature and their psychometric properties. 167 
 168 
 169 
 170 
 171 
 172 
 173 
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RESULTS 174 
Results of the database search and included studies:  175 
The database search resulted in 437 articles (Figure 1). References were 176 
uploaded into EndNote and duplicates were removed leaving 389 articles. 177 
After screening the titles and abstracts, 196 articles were excluded because 178 
they did not include validation of the HRQoL and 10 articles were excluded 179 
because they were published as abstracts in conferences and not as full 180 
papers. The full texts of 183 articles were obtained and reviewed. We 181 
excluded 108 articles that did not include the validation or evaluation of the 182 
psychometric properties of the HRQoL measures. Seventy-five articles were 183 
deemed eligible. After linking multiple reports of the same HRQoL measure, 184 
we identified 10 disease specific HRQoL measures in IBD (Table 3): 185 
1. Inflammatory bowel disease questionnaire (IBDQ) (26, 27) 186 
2. Shortened inflammatory bowel disease questionnaire (SIBDQ) (28)  187 
3. IBDQ was further shortened to 9 items, the IBDQ-9 (29).  188 
4.  Rating form of IBD patient concerns (RFIPC): (30).  189 
5. Edinburgh IBD quality of life questionnaire (EIBDQ): (31).  190 
6. The IBD disability score: (32),  191 
7. The IBD disability index: (33)  192 
8. Social Impact of Chronic Conditions–Inflammatory Bowel Disease 193 
(SICC-IBD) questionnaire (34).  194 
9. Crohn's disease perceived work disability questionnaire (CPWDQ) (35)  195 
10. Crohn's disease burden questionnaire: (36).  196 
 197 
 198 
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Assessing the psychometric properties of the HRQoL measures:  199 
A narrative summary of the included measures and their properties 200 
assessment is described in table 4. The IBDQ was the most widely used 201 
HRQoL in IBD. Although the original papers (26, 27) did not report all the 202 
psychometric properties, subsequent studies validated the IBDQ into different 203 
languages and have further proved its validity, internal consistency and 204 
reliability (37-51). The 32-item IBDQ questionnaire was shortened to 10 items 205 
(short IBDQ) (28) and 9 items (IBDQ-9) (29).  When evaluating the 206 
measurement properties for the rest of the HRQoL measures using the 207 
Terwee’s criteria, none has met all the criteria. Flooring and ceiling effects 208 
were not clearly reported when validating most of the HRQoL measures. 209 
When appraising the internal consistency of each measure, 8 measures 210 
achieved the recommended Cronbachα value of 0.7 -0.9 (22) (Table 1). Two 211 
measures did not have their internal consistency assessment reported in the 212 
literature. Ratings of the content validity were good for most of the measures 213 
as they used appropriate methods in generating items that covered various 214 
quality of life aspects of IBD (e.g. focus group, patient involvement, item 215 
generation and selection, measure reduction etc.). CD burden measure did 216 
not use an appropriate method to generate the items. Construct validity was 217 
appropriately assessed in almost all measures except IBD disability index, 218 
which was not fully validated. The HRQoL measures were compared with 219 
other measures of disease severity or quality of life. Six HRQoL measures 220 
correctly assessed the test-retest reliability and achieved the required values 221 
of the intraclass correlation coefficient, Kappa coefficients or confidence 222 
intervals. Most of the measures did not assess the inter-rater reliability as part 223 
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of the reliability testing. Three HRQoL measures had their responsiveness 224 
assessed in the original study report using the required statistics such as 225 
responsiveness ratio or paired t-tests. Seven measures did not have their 226 
responsiveness reported in literature. Measurement error evaluation and 227 
factor analysis was not assessed for most of the HRQoL measures.  228 
 229 
Assessing the methodology qualities of the HRQoL measures 230 
None of the HRQoL measures development studies showed adequate 231 
methodological quality in all COSMIN sections. Most of the publications 232 
scored excellent for content validity having captured the domains that are 233 
relevant to IBD patients through consultation with patients, and/or or literature 234 
review or other methods as described by Steiner and Norman (52). Although 235 
all HRQoL measures assessed the construct validity using other measures of 236 
HRQoL or disease activity, more than half of the measures scored “fair” either 237 
because they did not provide information on the missing items, a hypotheses 238 
regarding the direction and magnitude of correlations, sample size or 239 
achieved the required statistics. Most HRQoL measures were assessed for 240 
reliability, internal consistency and responsiveness. However, for most of 241 
them, this was not described in enough details to meet the COSMIN criteria. 242 
Most of the publications did not report how missing items were handled and 243 
how repeated measurements were conducted (mode of administration, 244 
sample size, statistical analyses and time interval for test-retest). Most of the 245 
studies did not include the assessment of measurement error or factor 246 
analysis in the measure development and were rated “poor” for these criteria. 247 
Table 5 shows the COMSIN ratings for the IBD specific HRQoL measures. 248 
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Assessing the level of credibility of the HRQoL measures: 249 
We used Cohen’s criteria (25) to appraise the degree establishment of the 250 
different HRQoL measures in IBD. According to Cohen’s criteria, only the 251 
IBDQ and SIBDQ were considered to be well-established measures, while the 252 
RFIC is approaching the level of well-established assessments. The rest were 253 
rated as promising assessments (Table 6). 254 
 255 
 256 
 257 
 258 
 259 
 260 
 261 
 262 
 263 
 264 
 265 
 266 
 267 
 268 
 269 
 270 
 271 
 272 
 273 
Page 11 of 41
https://mc.manuscriptcentral.com/ecco-jcc
Manuscripts submitted to Journal of Crohn's and Colitis
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
 12
Discussion:  274 
Assessing the HRQoL in patients with IBD is an important outcome measure 275 
in assessing the efficacy of new treatments or intervention. Typically, HRQoL 276 
measures have been developed and used to describe mean scores (or mean 277 
response) for a group of patients (e.g. those in each arm of a trial). The last 278 
decade has seen a rapid increase in the number of measures to assess the 279 
HRQoL in patients with IBD (32-36, 53-57). 280 
In this systematic review we identified 10 different HRQoL specific measures 281 
used for patients with IBD. We assessed the internal consistency, reliability, 282 
measurement error, content validity, factor analysis, construct validity, 283 
responsiveness, ceiling and flooring effects depending on the information 284 
obtained from the literature. Some of the HRQoL measures had some aspects 285 
of psychometric strength especially construct validity. However, they varied 286 
greatly in terms of their characteristics and most of them did not fulfill all the 287 
required properties proposed by Terwee et al (22). Notably, the IBDQ(26, 27), 288 
which is the most commonly used HRQoL measure in the literature, was not 289 
fully validated in the original study.  However it was further validated in 290 
subsequent studies that used it or translated it to other languages. The IBDQ 291 
has the advantage of having shorter versions (SIBDQ(28) and IBDQ-9(29)) 292 
and has been translated into different languages, which facilitate its use 293 
worldwide.  294 
We used the COSMIN checklist (23, 24) to appraise the methodological 295 
quality of the original HRQoL measures development studies. This included 296 
evaluation of the methodological quality of different properties such as the 297 
reliability, internal consistency, content validity, structural validity (factor 298 
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analysis), responsiveness, measurement error and construct validity. Using 299 
the COSMIN criteria of the methodology quality, the majority of studies were 300 
rated as “fair” to “poor” either because they did not reach the required 301 
standards or because of insufficient information. These studies are not 302 
necessarily of poor quality, but our results suggest that high quality studies 303 
are required to properly evaluate their measurement properties. 304 
We also assessed the level of establishment of the HRQoL measures using 305 
the Crohn’s criteria (25). We found that the IBDQ and SIBDQ were considered 306 
to be well-established measures, and the RFIC is approaching the level of 307 
well establishment. The rest were rated as promising assessments. 308 
We used a robust quality criteria (22) to systematically evaluate the 309 
psychometric properties of the identified HRQoL measures . We also used 310 
COSMIN checklist (23) to assess the methodological quality of the properties 311 
of the HRQoL measures in IBD. These criteria are increasingly used in 312 
systematic reviews of outcome measures (58-63).  The content validity, 313 
reliability, and validity of the COSMIN standards checklist were showed to be 314 
valid and reliable (64). However, a limitation of the COSMIN checklist and the 315 
quality properties of outcome measures (22-24) is that they were recently 316 
developed and might not be applicable to measures developed before its 317 
introduction. The inconsistency in the measurement properties may be 318 
explained by the fact that there was no agreement on a definition of the 319 
required measurement properties until recently. However, questionnaires still 320 
need to meet validity and reliability criteria and be described in a 321 
comprehensive manner. Studies included in the systematic review were 322 
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judged to be of poor methodological quality when evaluated by the COSMIN 323 
checklist if they were not descriptive enough to reach the COSMIN pre-324 
defined standards. Especially when it comes to missing items, if not clearly 325 
described, then most properties will be rated fair even if they were undertaken 326 
properly in the study. Most of the HRQoL have been recently developed and 327 
their validation is still ongoing. Hence, future studies are likely to provide 328 
additional evidence to support their validity and reliability.  329 
Although the COSMIN checklist and the quality criteria for the measurement 330 
properties were designed to be as objective as possible, reviewers’ judgments 331 
can be different. Therefore, two reviewers evaluated the included studies and 332 
a third reviewer was consulted in case of disagreement.  333 
We limited our search to English language studies due to the limited 334 
translation facilities available to us. Therefore, we might have missed HRQoL 335 
measures that were developed in other languages. However, our extensive 336 
and systematic search included studies that were carried out in non-English 337 
speaking countries but written in English. We did not find any mention of non 338 
English HRQoL measure specifically developed for IBD.  339 
Previous reviews of HRQoL measures in patients with IBD have limited their 340 
search to only a single concept of multi-dimensional HRQoL and included a 341 
limited number of measures (1, 65-68). There is no review in the literature that 342 
has evaluated the methodological quality of the measurement properties of 343 
the included HRQoL measures. One of the strengths of this systematic review 344 
is that it did not only focus on the single concept of multi-dimensional HRQoL, 345 
but took into account related concepts such as disease burden, work 346 
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productivity, fatigue, and social impact. We performed the literature search in 347 
a systematic way to identify all HRQoL measures used in IBD.  348 
To our knowledge, this is the first systematic review of HRQoL measures in 349 
IBD that systematically appraised the measurement properties and the 350 
methodological quality of the HRQoL measures using a robust and 351 
standardized approach. This facilitates good comparison between the HRQoL 352 
measures on their quality of their measurement properties. This review will 353 
better guide the use of HRQoL in various clinical and research settings. It will 354 
also help clinicians, researchers and the general public to better assess the 355 
scientific literature on HRQoL in IBD. Several new HRQoL measures are 356 
emerging and our study showed that most of the HRQoL are supported by 357 
evidence of at least one type of reliability or validity and further validation 358 
studies might support their use. The choice of HRQoL measure  in future will 359 
depend  on the context for which it  will be used (for example. social, disease 360 
burden, disability Ketc).  Until then, the IBDQ(26, 27) has the strongest 361 
published evidence of reliability and validity and it is well established in 362 
literature.  363 
 364 
 365 
 366 
 367 
 368 
 369 
 370 
 371 
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 397 
TABLES: 398 
Table 1: Quality criteria for rating the results of measurement properties 399 
(22) 400 
Properties  Ratings Quality criteria 
Reliability   
Internal consistency + Cronbach's alpha(s) between 0.70 – 0.90 
 ? No information available 
 − Cronbach's alpha(s) <0.70 or >0.90 or not done 
Reproducibility (test-
retest reliability) 
+ ICC or weighted kappa ≥0.70 OR Pearson's r ≥ 0.80 
 ? No information available 
 − ICC/weighted kappa <0.70 OR Pearson's r < 0.80 
Measurement error + Measurement error, smallest detectable change (SDC) 
are measured. SDC is less than MIC 
 ? No information available 
 − The study did not report a convincing evidence that the 
measurement error was assessed or/and it was more 
than the MIC 
Validity 
Content validity + Appropriate assessment of content validity was 
performed.  
 ? No information available 
 − Content validity was not assessed properly 
Factor analysis + Important factors/domains should explain at least 50% 
of the variance 
 ? No information available 
 − Important factors/ domains explain <50% of the 
variance 
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Construct validity 
hypothesis testing 
+ Correlation coefficient for the validity should be in the 
middle i.e. 0.4 -0.8  
 ? No information available 
 − Correlation coefficient for the validity is not between 0.4 
-0.8 
Responsiveness + Responsiveness was assessed using an appropriate 
method. 
 ? No information available 
 − Responsiveness was not assessed using an 
appropriate method. 
Ceiling and floor effects 
 + ≤15% of the respondents achieved the highest or 
lowest possible scores; 
 ? No information available 
 − >15% of the respondents achieved the highest or 
lowest possible scores, despite adequate design and 
methods; 
Interpretability + Mean and SD scores presented of at least four relevant 
subgroups of patients and MIC defined; 
 ? No information available 
 − Mean and SD scores were not presented of at least 
four relevant subgroups of patients or MIC was not 
defined 
 +, Positive rating; ?, no information available or  indeterminate rating; −, negative rating 
 401 
 402 
 403 
 404 
 405 
Page 18 of 41
https://mc.manuscriptcentral.com/ecco-jcc
Manuscripts submitted to Journal of Crohn's and Colitis
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
 19
Table 2: Cohen criteria for the level of credibility of the outcome 406 
measures (25) 407 
Category Criteria 
Well-established 
assessment 
I. The measure must have been presented ( validated) 
in at least two peer-reviewed articles by different 
investigators or investigatory teams.  
 II. Sufficient detail about the measure to allow critical 
evaluation and replication (e.g., measure and manual 
provided or available upon request).  
 III. Detailed (e.g., statistics presented) information 
indicating good validity and reliability in at least one 
peer-reviewed article.  
Approaching well 
established assessment 
I. The measure must have been presented in at least 
two peer-reviewed articles, which might be by the same 
investigator or investigatory team.  
 II. Sufficient detail about the measure to allow critical 
evaluation and replication (e.g., measure and manual 
provided or available upon request).  
 III. Validity and reliability information either presented in 
vague terms (e.g., no statistics presented) or only 
moderate values presented.  
Promising assessment I. The measure must have been presented in at least 
one peer-reviewed article. 
 II. Sufficient detail about the measure to allow critical 
evaluation and replication (e.g., measure and manual 
provided or available upon request).  
 III. Validity and reliability information either presented in 
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vague terms (e.g., no statistics presented) or moderate 
values presented.  
 408 
 409 
 410 
 411 
 412 
 413 
 414 
 415 
 416 
 417 
 418 
 419 
 420 
 421 
 422 
 423 
 424 
 425 
 426 
 427 
Page 20 of 41
https://mc.manuscriptcentral.com/ecco-jcc
Manuscripts submitted to Journal of Crohn's and Colitis
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
 21
Table 3: Summary of the specific HRQoL measures in IBD 
HRQoL 
measures 
Ref: Year  Domains covered Items 
numbers 
 IBDQ (26, 
27) 
1989 Disease specific HRQoL measure. It includes 
gastrointestinal symptoms, systemic symptoms, 
emotional dysfunction and social dysfunction 
domains. 
32 
 SIBDQ (28) 1996 A short version of IBDQ. It includes feeling tiredness, 
social aspects, sport activities, pain, depressed, 
winds, weight, feeling relaxed, going to toilet even if 
bowel are empty, and feeling angry 
10 
 IBDQ-9 (29). 2004 A shorter version of IBDQ-36. Includes Nausea, 
delay social engagement, passing winds, bowel 
movements, abdominal cramps, unwell, fatigue, 
feeling happy, energy level 
9 
 RFIPC (30).   1991 Four components are: a) impact of disease (e.g., 
being a burden, loss of energy, loss of bowel 
control); b) sexual intimacy; c) complications of 
disease (e.g., developing cancer, having surgery, 
dying early); and d) body stigma (e.g., feeling dirty or 
smelly) 
25 
 EIBDQ (31) 2002 Three underlying dimensions: a disease specific 
factor, a bowel specific factor and an information 
factor 
15 
 IBD 
disability 
score 
(32) 2013 Assess the disability of patients with IBD The 
questionnaire comprised the following domains; 
demographics, mobility, gastrointestinal-related 
problems, self- care, major life activities, mental 
health and interaction with the environment 
49 
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 IBD 
disability 
index 
(33) 2012 Based on the ICF coding system for IBD. General 
health, body functions, body structures and activities 
and participation, environmental factors.  
28 
 SICC-
IBD 
(34) 2012 Assess social dysfunction of IBD patients. It covers 
education, work, earnings and relationships 
8 
 CPWDQ (35) 2011 Assess the impact of Crohn’s disease on the patients 
at work. Asks about the impact of weight loss, fistula, 
surgery, symptoms, stoma, pain, using toilet 
facilities, medications, feelings, work relationship, 
work capacity, work stability, incontinence 
16 
 CD 
burden 
(36) 2010 It measures the burden of Crohn's disease (CD) and 
its treatment on HRQoL 
2 
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Table 4: The measurement properties of the specific HRQoL measures 
used in IBD 
 HRQoL 
measure
s 
Intern
al 
consis
tency 
Test-
retest 
reliabilit
y 
Measur
ement 
error 
Conte
nt 
validit
y 
Factor 
analys
is 
Const
ruct 
validit
y 
Respo
nsiven
ess 
Ceiling 
and 
floorin
g 
effect 
1. IBDQ + + + + + + + + 
2. SIBDQ + + - + - + + - 
3. IBDQ-9 + + - + - + + - 
4. RFIPC + + - + + - - - 
5. EIBDQ + - - + + + - - 
6. IBD 
disability 
score 
+ + + + - + -  
7. IBD 
disability 
index 
- - - + - - - - 
8. SICC-IBD + - - + - + - - 
9. CPWDQ + + - + + + - - 
10. CD 
burden 
- - - - - + - - 
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Table 5: The methodological quality of HRQoL measurement properties 
as described in the original development articles. 
 
HRQoL 
measur
es 
Ref: Internal 
consist
ency 
Reliab
ility 
Measu
rement 
error 
Content 
validity 
Fact
or 
anal
ysis 
Construct 
validity 
Responsi
veness 
1. IBDQ (26, 
27) 
Poor/fair Fair Poor Excellen
t 
Poor Fair  Fair 
2.  SIBDQ (28) Poor/fair Fair Poor Excellen
t 
Poor Fair Poor 
3.  IBDQ-9 (29). Fair Fair Poor Excellen
t 
Poor Fair Poor 
4. RFIPC (30).   Excellen
t 
Good Poor Excellen
t 
Excel
lent 
Excellent Poor 
5. EIBDQ (31) Fair Poor Poor Excellen
t 
Fair Fair Poor 
6. Allen et 
al 
(32) Poor Poor Fair Excellen
t 
Poor Good Poor 
7. IBD 
disabilit
y index 
(33) ? ? ? Excellen
t 
? ? ? 
8. SICC-
IBD 
(34) Poor Poor Poor Excellen
t 
Poor Good Poor 
9. CPWD
Q 
(35) Fair  Fair Poor Excellen
t 
Fair Fair Poor 
10. CD 
burden 
(36) Poor Poor Poor Poor Poor Fair Poor 
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Table 6: Assessing the level of establishment of the HRQoL measures 
Category Outcome measures 
Well-
established 
assessment 
IBDQ (26) (27) (69) (38, 41, 70, 71), SIBDQ (28, 72-75) 
Approaching 
well-
established 
assessment 
RFIC (30, 76-78) 
Promising 
assessment 
UK-IBDQ(51), IBDQ-9(29), SICC-IBD(34), CPWDQ(35),  Allen et al(32), 
EIBDQ(31) , CD burden(36), IBD disability index(33) 
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APPENDICES: 
Appendix 1: PRISMA checklist for systematic search 
Section/topic # Checklist item Reported on 
page # 
TITLE 
Title 1 Identify the report as a systematic review, meta-
analysis, or both. 
Title of the 
section 
ABSTRACT 
Structured 
summary 
2 Provide a structured summary including, as applicable: 
background; objectives; data sources; study eligibility 
criteria, participants, and interventions; study appraisal 
and synthesis methods; results; limitations; conclusions 
and implications of key findings; systematic review 
registration number. 
2 
INTRODUCTION 
Rationale 3 Describe the rationale for the review in the context of 
what is already known.  
4-5 
Objectives 4 Provide an explicit statement of questions being 
addressed with reference to participants, interventions, 
comparisons, outcomes, and study design (PICOS).  
4-5 
METHODS 
Protocol and 
registration 
5 Indicate if a review protocol exists, if and where it can 
be accessed (e.g., Web address), and, if available, 
provide registration information including registration 
number.  
N/A 
Eligibility criteria 6 Specify study characteristics (e.g., PICOS, length of 
follow-up) and report characteristics (e.g., years 
considered, language, publication status) used as 
criteria for eligibility, giving rationale. 
7 
Information 
sources  
7 Describe all information sources (e.g., databases with 
dates of coverage, contact with study authors to identify 
additional studies) in the search and date last searched.  
6 
Search 8 Present full electronic search strategy for at least one 
database, including any limits used, such that it could 
be repeated. 
32 
Study selection  9 State the process for selecting studies (i.e., screening, 
eligibility, included in systematic review, and, if 
applicable, included in the meta-analysis).  
7 
Data collection 
process 
10 Describe method of data extraction from reports (e.g., 
piloted forms, independently, in duplicate) and any 
processes for obtaining and confirming data from 
investigators. 
7 
Data items  11 List and define all variables for which data were sought 
and any assumptions and simplifications made. 
6-7 
Risk of bias in 
individual 
studies 
12 Describe methods used for assessing risk of bias of 
individual studies (including specification of whether this 
was done at the study or outcome level), and how this 
information is to be used in any data synthesis. 
N/A 
Summary 
measures 
13 State the principal summary measures (e.g., risk ratio, 
difference in means).  
Tables 3-6 
Synthesis of 
results 
14 Describe the methods of handling data and combining 
results of studies, if done, including measures of 
N/A 
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consistency (e.g., I
2
) for each meta-analysis. 
Risk of bias 
across studies 
15 Specify any assessment of risk of bias that may affect 
the cumulative evidence (e.g., publication bias, 
selective reporting within studies).   
N/A 
Additional 
analyses 
16 Describe methods of additional analyses (e.g., 
sensitivity or subgroup analyses, meta-regression), if 
done, indicating which were pre-specified. 
N/A 
RESULTS 
Study selection 17 Give numbers of studies screened, assessed for 
eligibility, and included in the review, with reasons for 
exclusions at each stage, ideally with a flow diagram. 
Figure 1 
Study 
characteristics 
18 For each study, present characteristics for which data 
were extracted and provide the citations. 
Tables 3-6 
Risk of bias 
within studies 
19 Present data on risk of bias of each study and, if 
available, any outcome-level assessment (see Item 12). 
N/A 
Results of 
individual 
studies 
20 For all outcomes considered (benefits or harms), 
present, for each study: (a) simple summary data for 
each intervention group and (b) effect estimates and 
confidence intervals, ideally with a forest plot. 
N/A 
Synthesis of 
results  
21 Present results of each meta-analysis done, including 
confidence intervals and measures of consistency. 
N/A 
Risk of bias 
across studies 
22 Present results of any assessment of risk of bias across 
studies  (see Item 15). 
N/A 
Additional 
analysis 
23 Give results of additional analyses, if done (e.g., 
sensitivity or subgroup analyses, meta-regression [see 
Item 16]). 
N/A 
DISCUSSION 
Summary of 
evidence 
24 Summarize the main findings including the strength of 
evidence for each main outcome; consider their 
relevance to key groups (e.g., health care providers, 
users, and policy makers). 
13 
Limitations 25 Discuss limitations at study and outcome level (e.g., 
risk of bias), and at review level (e.g., incomplete 
retrieval of identified research, reporting bias). 
13-15 
Conclusions 26 Provide a general interpretation of the results in the 
context of other evidence, and implications for future 
research. 
16 
FUNDING 
Funding  27 Describe sources of funding for the systematic review 
and other support (e.g., supply of data); role of funders 
for the systematic review. 
17 
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Appendix 2: Electronic database search strategy 
 
Database: Ovid  EMBASE 1900 - 2013 
 
Search terms No. of 
references 
1. inflammatory bowel disease.mp. or *enteritis/ or exp inflammatory 
bowel disease/ or exp ulcerative colitis/ or exp Crohn disease/ or exp 
colitis/ 
156123  
2. 
limit 1 to (human and english language and yr="1900 - 2013") 92702  
3. 
exp ulcerative colitis/ or Colitis Gravis.mp. 50344  
4. 
limit 3 to (human and english language and yr="1900 - 2013") 31100  
5. 
Granulomatous Enteritis.mp. or *enteritis/ 25798  
6. 
limit 5 to (human and english language and yr="1900 - 2013") 15054  
7. 
Regional Enteritis.mp. or exp Crohn disease/ 57543  
8. 
limit 7 to (human and english language and yr="1900 - 2013") 39551  
9. 
ileitis/ or exp Crohn disease/ or Regional Ileitis.mp. 60090  
10.
limit 9 to (human and english language and yr="1900 - 2013") 40854  
11.
exp Crohn disease/ or Terminal Ileitis.mp. 57655  
12.
limit 11 to (human and english language and yr="1900 - 2013") 39576  
13.
exp proctitis/ or exp proctocolitis/ or Idiopathic Proctocolitis.mp. 5336  
14.
limit 13 to (human and english language and yr="1900 - 2013") 2972  
15.
2 or 4 or 6 or 8 or 10 or 12 or 14 93155  
16.
quality of life.mp. or *"quality of life"/ 299007  
17.
limit 16 to (human and english language and yr="1900 - 2013") 230656  
18.
*questionnaire/ or *"quality of life"/ or *outcomes research/ or patient 
reported outcomes.mp. 
82767  
19.
limit 18 to (human and english language and yr="1900 - 2013") 63415  
20.
health related outcome measure.mp. 2  
21.
limit 20 to (human and english language and yr="1900 - 2013") 2  
22.
health status.mp. or *health status/ 102973  
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23.
limit 22 to (human and english language and yr="1900 - 2013") 78926  
24.
patient outcome assessment.mp. or *outcome assessment/ 10674  
25.
limit 24 to (human and english language and yr="1900 - 2013") 9037  
26.
17 or 19 or 21 or 23 or 25 319296  
27.
15 and 26 4060  
28.
validation.mp. or *instrument validation/ or *validation study/ or 
*validation process/ 
208947  
29.
limit 28 to (human and english language and yr="1900 - 2013") 121475  
30.
*qualitative validity/ or *discriminant validity/ or *external validity/ or 
*validity/ or *consensual validity/ or *criterion related validity/ or 
validity.mp. or *concurrent validity/ or *content validity/ or *face 
validity/ or *construct validity/ or *convergent validity/ or *internal 
validity/ or *predictive validity/ 
143520  
31.
limit 30 to (human and english language and yr="1900 - 2013") 96200  
32.
*reliability/ or *questionnaire/ or Reliability of Results.mp. or 
*reproducibility/ 
28158  
33.
limit 32 to (human and english language and yr="1900 - 2013") 19560  
34.
29 or 31 or 33 201034  
35.
27 and 34 217  
 
 
Database: Ovid MEDLINE(R) 1860 to 2013, Ovid MEDLINE(R) In-Process & Other Non-
Indexed Citations 1860-2013 
 
 
Search terms No. of 
references 
1. exp Inflammatory Bowel Diseases/ 59020  
2. 
limit 1 to (english language and yr="1860 - 2013") 47115  
3. 
Colitis, Ulcerative/ 26947  
4. 
limit 3 to (english language and yr="1860 - 2013") 20565  
5. 
Crohn Disease/ 30001  
6. 
limit 5 to (english language and yr="1860 - 2013") 23767  
7. 
Crohn Disease/ 30001  
8. 
limit 7 to (english language and yr="1860 - 2013") 23767  
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9. 
Colitis, Ulcerative/ 26947  
10.
limit 9 to (english language and yr="1860 - 2013") 20565  
11.
Idiopathic Proctocolitis.mp. 32  
12.
limit 11 to (english language and yr="1860 - 2013") 13  
13.
Colitis Gravis.mp. 7  
14.
limit 13 to (english language and yr="1860 - 2013") 1  
15.
Regional Enteritis.mp. [mp=title, abstract, original title, name of substance 
word, subject heading word, keyword heading word, protocol 
supplementary concept word, rare disease supplementary concept word, 
unique identifier] 
809  
16.
limit 15 to yr="1860 - 2013" 808  
17.
Granulomatous Enteritis.mp. [mp=title, abstract, original title, name of 
substance word, subject heading word, keyword heading word, protocol 
supplementary concept word, rare disease supplementary concept word, 
unique identifier] 
123  
18.
limit 17 to (english language and yr="1860 - 2013") 113  
19.
Regional Ileitis.mp. [mp=title, abstract, original title, name of substance 
word, subject heading word, keyword heading word, protocol 
supplementary concept word, rare disease supplementary concept word, 
unique identifier] 
226  
20.
limit 19 to (english language and yr="1860 - 2013") 161  
21.
Granulomatous Colitis.mp. [mp=title, abstract, original title, name of 
substance word, subject heading word, keyword heading word, protocol 
supplementary concept word, rare disease supplementary concept word, 
unique identifier] 
322  
22.
limit 21 to (english language and yr="1860 - 2013") 261  
23.
Terminal Ileitis.mp. [mp=title, abstract, original title, name of substance 
word, subject heading word, keyword heading word, protocol 
supplementary concept word, rare disease supplementary concept word, 
unique identifier] 
347  
24.
limit 23 to (english language and yr="1860 - 2013") 159  
25.
2 or 4 or 6 or 8 or 10 or 12 or 14 or 16 or 18 or 20 or 22 or 24 47643  
26.
*"Quality of Life"/ or *"Outcome Assessment (Health Care)"/ or *Patient 
Satisfaction/ or patient reported outcomes.mp. or *Treatment Outcome/ 
93494  
27.
limit 26 to (english language and humans and yr="1860 - 2013") 82097  
28.
health status.mp. or *Health Status/ 103700  
29.
limit 28 to (english language and humans and yr="1860 - 2013") 87567  
30.
Life Qualities.mp. or *"Quality of Life"/ 51005  
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31.
limit 30 to (english language and humans and yr="1860 - 2013") 44084  
32.
Life Quality.mp. or *"Quality of Life"/ 53401  
33.
limit 32 to (english language and humans and yr="1860 - 2013") 45260  
34.
27 or 29 or 31 or 33 157376  
35.
25 and 34 689  
36.
*Validation Studies/ or validation.mp. or *Validation Studies as Topic/ 146196  
37.
limit 36 to (english language and humans and yr="1860 - 2013") 94702  
38.
Reliability of Results.mp. or exp "Reproducibility of Results"/ 268135  
39.
limit 38 to (english language and humans and yr="1860 - 2013") 193504  
40.
validity.mp. or *"Reproducibility of Results"/ or *Questionnaires/ 125565  
41.
limit 40 to (english language and humans and yr="1860 - 2013") 91596  
42.
(Reliability and Validity).mp. [mp=title, abstract, original title, name of 
substance word, subject heading word, keyword heading word, protocol 
supplementary concept word, rare disease supplementary concept word, 
unique identifier] 
29168  
43.
limit 42 to (english language and humans and yr="1860 - 2013") 23742  
44.
*"Reproducibility of Results"/ or Reproducibility.mp. 296317  
45.
limit 44 to (english language and humans and yr="1860 - 2013") 206824  
46.
*"Reproducibility of Results"/ or Face validity.mp. or *Questionnaires/ 31078  
47.
limit 46 to (english language and humans and yr="1860 - 2013") 26488  
48.
*"Outcome Assessment (Health Care)"/ or Content validity.mp. 23114  
49.
limit 48 to (english language and humans and yr="1860 - 2013") 20841  
50.
*Psychometrics/ or Construct validity.mp. 16807  
51.
limit 50 to (english language and humans and yr="1860 - 2013") 14153  
52.
concurrent validity.mp. 3787  
53.
limit 52 to (english language and humans and yr="1860 - 2013") 3242  
54.
*Psychological Tests/ or Convergent validity.mp. or *Psychiatric Status 22810  
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Rating Scales/ 
55.
limit 54 to (english language and humans and yr="1860 - 2013") 15939  
56.
Checklist.mp. 18282  
57.
limit 56 to (english language and humans and yr="1860 - 2013") 14783  
58.
instrument.mp. [mp=title, abstract, original title, name of substance word, 
subject heading word, keyword heading word, protocol supplementary 
concept word, rare disease supplementary concept word, unique 
identifier] 
76392  
59.
limit 58 to (english language and humans and yr="1860 - 2013") 48347  
60.
*Quality Indicators, Health Care/ or *"Quality of Health Care"/ or 
Performance measures.mp. 
36940  
61.
limit 60 to (english language and humans and yr="1860 - 2013") 27367  
62.
37 or 39 or 41 or 43 or 45 or 47 or 49 or 51 or 53 or 55 or 57 or 59 or 61 406612  
63.
35 and 62 165  
 
 
 
Database: Ovid PsycINFO 1860 - 2013 
 
 
Search terms No. of 
reference
s  
1. exp Ulcerative Colitis/ or inflammatory bowel disease.mp. 669  
2. 
limit 1 to yr="1860 - 2013" 664  
3. 
Crohn's disease.mp. 382  
4. 
limit 3 to yr="1860 - 2013" 381  
5. 
Crohn disease.mp. 22  
6. 
limit 5 to (english language and yr="1860 - 2013") 15  
7. 
Idiopathic Proctocolitis.mp. [mp=title, abstract, heading word, table of 
contents, key concepts, original title, tests & measures] 
0  
8. 
limit 7 to (english language and yr="2013") 0  
9. 
Proctocolitis.mp. 1  
10. 
limit 9 to (english language and yr="1860 - 2013") 1  
11. 
exp Ulcerative Colitis/ or exp Colitis/ or Colitis.mp. 771  
12. 
limit 11 to (english language and yr="1860 - 2013") 619  
Page 32 of 41
https://mc.manuscriptcentral.com/ecco-jcc
Manuscripts submitted to Journal of Crohn's and Colitis
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
 33
13. 
Granulomatous Enteritis.mp. [mp=title, abstract, heading word, table 
of contents, key concepts, original title, tests & measures] 
0  
14. 
limit 13 to (english language and yr="1860 - 2013") 0  
15. 
Terminal Ileitis.mp. [mp=title, abstract, heading word, table of 
contents, key concepts, original title, tests & measures] 
0  
16. 
limit 15 to (english language and yr="1860 - 2013") 0  
17. 
2 or 4 or 6 or 8 or 10 or 12 or 14 or 16 1234  
18. 
quality of life.mp. or exp "Quality of Life"/ 45441  
19. 
limit 18 to (english language and yr="1860 - 2013") 41844  
20. 
*"Quality of Life"/ or *Treatment Outcomes/ or *Measurement/ or 
patient reported outcomes.mp. 
68202  
21. 
limit 20 to (english language and yr="1860 - 2013") 63212  
22. 
health related outcome measure.mp. 0  
23. 
limit 22 to (english language and yr="1860 - 2013") 0  
24. 
*Performance Tests/ or *"Quality of Services"/ or Performance 
measures.mp. 
8019  
25. 
limit 24 to (english language and yr="1860 - 2013") 7716  
26. 
questionnaire.mp. or *Questionnaires/ 219432  
27. 
limit 26 to (english language and yr="1860 - 2013") 196473  
28. 
19 or 21 or 23 or 25 or 27 272418  
29. 
17 and 28 191  
30. 
*Statistical Validity/ or *Test Reliability/ or *Measurement/ or *Test 
Construction/ or validation.mp. or *Questionnaires/ or 
*Psychometrics/ or *Test Validity/ or *Foreign Language Translation/ 
131989  
31. 
limit 30 to (english language and yr="1860 - 2013") 117809  
32. 
*Test Validity/ or *Statistical Validity/ or validity.mp. 121770  
33. 
limit 32 to (english language and yr="1860 - 2013") 109074  
34. 
Face validity.mp. 1307  
35. 
limit 34 to (english language and yr="1860 - 2013") 1255  
36. 
*Statistical Reliability/ or Reliability.mp. or *Interrater Reliability/ or 
*Test Reliability/ 
75133  
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37. 
limit 36 to (english language and yr="1860 - 2013") 66708  
38. 
*Statistical Analysis/ or *Rating Scales/ or *Test Reliability/ or 
Reproducibility.mp. or *Test Validity/ 
70936  
39. 
limit 38 to (english language and yr="1860 - 2013") 62751  
40. 
Construct validity.mp. or *Test Validity/ 48892  
41. 
limit 40 to yr="1860 - 2013" 48706  
42. 
Content validity.mp. 2741  
43. 
limit 42 to (english language and yr="1860 - 2013") 2529  
44. 
Convergent validity.mp. 4478  
45. 
limit 44 to (english language and yr="1860 - 2013") 3963  
46. 
31 or 33 or 35 or 37 or 39 or 41 or 43 or 45 201286  
47. 
29 and 46 35  
 
 
Abbreviations: 
1. “.mp” stands for multi-purpose. MP search which searches several fields at once. The 
fields searched by a .MP includes the Title, Original Title, Abstract, Subject Heading, 
Name of Substance, and Registry Word fields.  
2. “Exp” means Explode. This is a function of Ovid to retrieve citations using the  
selected term and all of its more specific terms.  
3. “ * “means focus the search on the search terms in the subject heading. Articles are 
considered when the major point or focus of the article is the search term.  
4. “ or “ combines search results that include any of the search terms 
5. “and” combines search results that included both / all search terms 
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